These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 18820711)
1. G-CSF-induced thrombocytopenia in a healthy donor. Minelli O; Falzetti F; Di Ianni M; Onorato M; Plebani S; Silvani C; Tabilio A Bone Marrow Transplant; 2009 Feb; 43(3):263-4. PubMed ID: 18820711 [No Abstract] [Full Text] [Related]
2. Profound thrombocytopenia related to G-CSF. Kovacic JC; Macdonald P; Freund J; Rasko JE; Allan R; Fernandes VB; Ma D; Moore J; Graham RM Am J Hematol; 2007 Mar; 82(3):229-30. PubMed ID: 17034024 [TBL] [Abstract][Full Text] [Related]
3. Severe reversible thrombocytopenia caused by recombinant human granulocyte colony-stimulating factor in an AIDS patient receiving chronic ganciclovir therapy. Holtzer CD; Stanley HD; Jacobson MA AIDS; 1997 Sep; 11(11):1403-5. PubMed ID: 9302457 [No Abstract] [Full Text] [Related]
4. [Collection of hematopoietic progenitor cells from healthy donors]. Bojanić I; Cepulić BG; Mazić S Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352 [TBL] [Abstract][Full Text] [Related]
5. Possible harmful effects of short course granulocyte colony-stimulating factor in normal donors. Goldman JM; Madrigal JA; Pamphilon D Br J Haematol; 2006 Dec; 135(5):651-2. PubMed ID: 17054429 [No Abstract] [Full Text] [Related]
7. Regeneration, health status and quality of life after rhG-CSF-stimulated stem cell collection in healthy donors: a cross-sectional study. Leitner GC; Baumgartner K; Kalhs P; Biener D; Greinix HT; Hoecker P; Worel N Bone Marrow Transplant; 2009 Mar; 43(5):357-63. PubMed ID: 18936736 [TBL] [Abstract][Full Text] [Related]
8. Short and long-term safety of lenograstim administration in healthy peripheral haematopoietic progenitor cell donors: a single centre experience. Martino M; Console G; Dattola A; Callea I; Messina G; Moscato T; Massara E; Irrera G; Fedele R; Gervasi A; Bresolin G; Iacopino P Bone Marrow Transplant; 2009 Aug; 44(3):163-8. PubMed ID: 19182833 [TBL] [Abstract][Full Text] [Related]
9. Recombinant human granulocyte colony-stimulating factor significantly decreases the expression of CXCR3 and CCR6 on T cells and preferentially induces T helper cells to a T helper 17 phenotype in peripheral blood harvests. Sun LX; Ren HY; Shi YJ; Wang LH; Qiu ZX Biol Blood Marrow Transplant; 2009 Jul; 15(7):835-43. PubMed ID: 19539215 [TBL] [Abstract][Full Text] [Related]
10. Kinetics of granulocyte colony-stimulating factor in the human milk of a nursing donor receiving treatment for mobilization of the peripheral blood stem cells. Kaida K; Ikegame K; Fujioka T; Taniguchi Y; Inoue T; Hasei H; Tamaki H; Yoshihara S; Kawase I; Ogawa H Acta Haematol; 2007; 118(3):176-7. PubMed ID: 17914246 [No Abstract] [Full Text] [Related]
11. Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and other immunomodulatory therapies for the treatment of infectious diseases in solid organ transplant recipients. Page AV; Liles WC Curr Opin Organ Transplant; 2008 Dec; 13(6):575-80. PubMed ID: 19060545 [TBL] [Abstract][Full Text] [Related]
14. Novel strategies for granulocyte colony-stimulating factor treatment of severe prolonged neutropenia suggested by mathematical modeling. Shochat E; Rom-Kedar V Clin Cancer Res; 2008 Oct; 14(20):6354-63. PubMed ID: 18927273 [TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of consecutive cycles of granulocyte-colony stimulating factor, and an intracoronary CD133+ cell infusion in patients with chronic refractory ischemic heart disease: the G-CSF in angina patients with IHD to stimulate neovascularization (GAIN I) trial. Kovacic JC; Macdonald P; Feneley MP; Muller DW; Freund J; Dodds A; Milliken S; Tao H; Itescu S; Moore J; Ma D; Graham RM Am Heart J; 2008 Nov; 156(5):954-63. PubMed ID: 19061712 [TBL] [Abstract][Full Text] [Related]
16. Enhanced external counterpulsation promotes growth cytokines-mediated myocardial angiogenesis in a porcine model of hypercholesterolemia. Luo JY; Wu GF; Xiong Y; Chen GW; Xie Q; Yang DY; He XH; Zhang Y; Liu DH; Wang KJ; Ma H; Zheng ZS; DU ZM Chin Med J (Engl); 2009 May; 122(10):1188-94. PubMed ID: 19493469 [TBL] [Abstract][Full Text] [Related]
17. Etoposide 1.0 g/m2 or 1.5 g/m2 combined with granulocyte colony-stimulating factor for mobilization of peripheral blood stem cells in patients with malignancy: efficacy and toxicity. Li B; Yang JL; Shi YK; He XH; Han XH; Zhou SY; Liu P; Yang S; Zhang CG Cytotherapy; 2009; 11(3):362-71. PubMed ID: 19037766 [TBL] [Abstract][Full Text] [Related]
18. G-CSF and GM-CSF concentrations and receptor expression in peripheral blood leukemic cells from patients with chronic myelogenous leukemia. Lee J; Kim Y; Lim J; Kim M; Han K Ann Clin Lab Sci; 2008; 38(4):331-7. PubMed ID: 18988925 [TBL] [Abstract][Full Text] [Related]
19. An assessment of erythroid response to epoetin alpha as a single agent versus in combination with granulocyte- or granulocyte-macrophage-colony-stimulating factor in myelodysplastic syndromes using a meta-analysis approach. Mundle S; Lefebvre P; Vekeman F; Duh MS; Rastogi R; Moyo V Cancer; 2009 Feb; 115(4):706-15. PubMed ID: 19152429 [TBL] [Abstract][Full Text] [Related]
20. Factors associated with peripheral blood stem cell yield in volunteer donors mobilized with granulocyte colony-stimulating factors: the impact of donor characteristics and procedural settings. Wang TF; Wen SH; Chen RL; Lu CJ; Zheng YJ; Yang SH; Chu SC; Kao RH; Chen SH Biol Blood Marrow Transplant; 2008 Nov; 14(11):1305-11. PubMed ID: 18940686 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]